Top Koneksa Alternatives

ClinCapture aims to develop software that has the potential to save lives. Their innovative technology not only lowers the expenses associated with clinical trials but also enhances the efficiency of data collection while ensuring the confidentiality of patient information. Additionally, ClinCapture serves as a comprehensive platform that supports the assessment and advancement of drugs, biologics, and medical devices, which can address a diverse range of health issues. By prioritizing both cost-effectiveness and patient privacy, ClinCapture is dedicated to improving the overall landscape of clinical research.

Castor is an innovative clinical trial platform designed to simplify data management through electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). Its flexible and user-friendly interface allows researchers to collect, manage, and analyze clinical data efficiently across multiple sites and remote patients. Castor’s tools are specifically designed to support decentralized clinical trials (DCTs), enabling real-time data monitoring, remote recruitment, and seamless patient engagement. The platform ensures full regulatory compliance, including HIPAA, GDPR, and 21 CFR Part 11, and is certified for ISO standards. With more than 50,000 global users, Castor continues to improve the speed and quality of clinical trials through integrated, scalable solutions that reduce administrative burdens and accelerate research.

The Medidata Clinical Cloud is an advanced platform crafted to transform the clinical trial experience for patients, sponsors, CROs, and research institutions alike. As the only all-encompassing technological solution dedicated solely to clinical research, this platform covers the entire spectrum of research from its initial stages to final outcomes. It empowers organizations within the life sciences and medical device industries to cut down on development costs, effectively manage risks, and accelerate the launch of new treatments and devices into the market. Regardless of your choice for clinical trial strategies, the advantages of the Medidata Clinical Cloud will be at your disposal. Medidata stands at the leading edge of the digital transformation in clinical research. By harnessing the capabilities of artificial intelligence, machine learning, and advanced analytics, our platform facilitates connections among researchers, study coordinators, investigators, and patients, ultimately speeding up the research process. Furthermore, it features a regulatory-compliant and patient-centric electronic informed consent solution for clinical trials, which improves the experience for everyone involved. This seamless integration of cutting-edge technology not only optimizes operational efficiency but also significantly uplifts the overall quality and integrity of clinical research endeavors. Thus, adopting the Medidata Clinical Cloud means embracing a future where clinical trials are more efficient and patient-focused than ever before.

At PathAI, our mission centers on improving patient outcomes by leveraging reliable AI-powered technology alongside strong partnerships, aiming to provide the most accurate diagnoses and effective treatments available. Our cutting-edge translational platform, backed by a team of proficient scientists, biostatisticians, and machine learning specialists, explores and analyzes novel cellular and tissue patterns to reveal pathology-related characteristics that lead to transformative insights across all phases of drug development and various therapeutic areas. By utilizing consistent and trustworthy technology, our systems seek to minimize observer variability while enhancing patient selection and stratification, thereby ensuring that the most appropriate patients participate in each trial, which significantly increases the prospects of successful results. Furthermore, our advanced technology determines the most precise cut points, which allows us to improve accuracy and increase the number of patients who positively test for biomarkers, ultimately facilitating the development of more effective treatments. This unwavering dedication to excellence not only places us at the forefront of healthcare innovation but also drives our commitment to shaping the future of medicine through advanced analytics and collaborative efforts, ensuring a healthier tomorrow for all.

Mahalo Health is a comprehensive digital health platform designed to accelerate the development of patient-centered digital health solutions and clinical trials. It offers an array of prebuilt modules that enable the rapid deployment of customizable white-label applications tailored to specific therapeutic areas. The platform is equipped with advanced data capabilities, which include a predictive health engine for anticipating diseases and diagnoses, a behavior modification engine that promotes healthy patient habits, and a notification system that guarantees prompt communication via push notifications, SMS, or emails. Mahalo Health is dedicated to upholding rigorous security and compliance standards, adhering to regulations like HIPAA, GCP, ISO27001, and GDPR. Its diverse service offerings span various therapeutic domains, such as diabetes management, cognitive health, cardiovascular care, musculoskeletal issues, mental well-being, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Furthermore, Mahalo Health not only enhances patient engagement but also improves health outcomes by equipping healthcare providers with innovative digital tools and solutions that adapt to the evolving needs of their patients. This commitment to innovation ensures that healthcare delivery is both efficient and personalized.

The LARVOL CLIN platform provides an extensive array of AI-powered data analytics and intelligence tailored for oncology and drug development professionals, integrating more than 100,000 cancer clinical trials alongside detailed outcomes, digitized Kaplan-Meier curves, forest plots, and real-time social media commentary from a community of over 5,000 oncologists. Users gain access to a cohesive interface that facilitates searches based on condition, intervention, or trial ID, enriched by expert-curated insights and visually appealing dashboards that enhance decision-making. Moreover, the platform includes functionalities such as conference tracking, comprehensive databases for biomarkers and diagnostics, and in-depth market intelligence reports collected from upwards of 25,000 sources, including regulatory agencies, clinical trial registries, and various scientific conferences. This tool is specifically designed to assist pharmaceutical and biotech teams in interpreting trial results, identifying trends, understanding mechanisms of action, and pinpointing biomarkers within disease pipelines, utilizing sophisticated search filters, heat maps, and real-time notifications. By adopting this all-encompassing strategy, users are ensured that they remain knowledgeable and prepared to make insightful choices amid the fast-paced advancements in the field. Ultimately, LARVOL CLIN stands out as an indispensable resource for those navigating the complexities of oncology research and drug development.

Suvoda stands as a prominent player in the arena of clinical trial technology, concentrating on complex, life-saving research in areas such as oncology, central nervous system disorders, and rare diseases. Founded in 2013, the organization offers a robust platform equipped with Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all designed to optimize critical patient engagements. Their cutting-edge software ensures a seamless user experience, facilitating precise randomization, effective drug supply management, and prompt data gathering. Committed to enhancing patient comprehension and reducing the burdens faced by trial sites, Suvoda's solutions are crafted to adapt to the growing intricacies of clinical research. Headquartered near Philadelphia, with additional branches throughout Europe and Asia, Suvoda has proudly aided in the execution of over 1,500 trials across more than 85 countries, demonstrating their extensive global influence and proficiency in the industry. Their unwavering focus on innovation and high standards establishes them as an essential ally in the progress of clinical research, paving the way for future breakthroughs and transformations in the field.

AcceleTrial™ removes the guesswork involved in selecting and activating clinical trial sites. It operates on a Study Start-up Management System (SSMS) that prioritizes objective data over self-reported metrics, granting access to a vast repository of thousands of ranked sites around the world. These sites are assessed based on three crucial criteria: their relevant therapeutic knowledge, experience in conducting clinical trials, and available patient data. By utilizing this data-driven approach, you can effectively identify the best-fit sites globally for your clinical trials. The platform also supports a quick activation of these sites for patient enrollment through an automated "push and pull" system that is available in multiple languages. Moreover, it simplifies the document collection process with pre-filled templates and offers real-time activity tracking capabilities. Users can quickly adopt the system since it is cloud-based, requiring very little IT setup or training to get going. Additionally, AcceleTrial™ seamlessly integrates with CTMS or other clinical trial management software, which significantly boosts overall operational effectiveness. This groundbreaking method not only enhances the precision of site selection but also speeds up the entire process of study initiation, ensuring that trials can commence without unnecessary delays. Ultimately, AcceleTrial™ represents a significant advancement in the efficiency and reliability of clinical trial management.

Advancing artificial intelligence to eliminate the necessity for trial and error in healthcare, our digital twins enable rapid and reliable clinical trials. We prioritize research in fields such as neuroscience, immunology, and metabolic disorders, among others. TwinRCTs accelerate full enrollment by requiring fewer participants to achieve the same statistical power as traditional trial methods. This innovative strategy drastically cuts down on the time needed for late-stage study enrollment. Furthermore, TwinRCTs improve the detection of treatment effects in early-stage research by increasing statistical power without needing more participants. They allow researchers to make well-informed decisions based on initial findings and assist in attracting additional participants to clinical trials. By utilizing smaller control groups, TwinRCTs also enhance the likelihood of participants receiving the experimental treatment. Our dedication to ensuring that clinical trials with digital twins achieve regulatory approval remains steadfast. Unlearn is leading the charge in revolutionizing the healthcare industry through the pioneering use of artificial intelligence, crafting and applying cutting-edge generative models that utilize extensive datasets gathered from prior patient studies. This shift in methodology not only optimizes research efficiency but also significantly improves the effectiveness of clinical trials. The future of medicine is being reshaped as we continue to refine these innovative approaches.

TrialPoint™ electronic data capture (EDC) system stands out for its exceptional adaptability and ease of use, earning the trust of coordinators across the board. Our expert data managers are dedicated to converting clinical protocols into user-friendly metadata dictionaries, ensuring that TrialPoint™ is customized to meet your specific needs instead of complicating your workflows. The platform is designed to support any randomization string, media uploads, or coding dictionaries, and it includes features that allow for the concealment of treatment assignments from users. To promote efficient data collection, the system intelligently identifies visit windows and sends out alerts and reminders, which aids in keeping the whole team synchronized and focused. In today’s environment, integrating patient-reported health outcomes and quality of life assessments into clinical trials has become standard, often resulting in challenges with protocol adherence. Discover the ePRO module offered by TrialPoint, which can be tailored to fit any quality of life questionnaire or patient diary, ensuring a smooth experience for participants. This remarkable flexibility not only boosts compliance but also improves the overall integrity and quality of the data gathered in clinical research. By utilizing TrialPoint™, you can streamline your trial processes and enhance participant engagement significantly.

HumanFirst is developing a robust operational framework to enable decentralized trials and deliver distributed care directly within the home environment. Our comprehensive workflow management platform provides your team with critical tools designed for customized remote monitoring solutions. Featuring a timeline-driven interface, our platform effectively supports all phases from assessment to implementation and ongoing management. We have compiled a diverse range of connected sensor technologies in Atlas, categorizing physiological and behavioral metrics into over 150 unique classifications. Our expertise spans a wide array of medical conditions across more than 25 therapeutic areas, allowing for a thorough understanding of patient needs. By leveraging the open-access V3 Framework, we have meticulously reviewed over 500,000 pieces of evidence to pinpoint the most effective technologies for measuring digital endpoints. The implementation of remote monitoring is intended to significantly improve patient outcomes, while also providing an opportunity for you to showcase your connected product on Atlas, thereby enriching a vast network of innovations. Our commitment to publishing open-access research has earned recognition in prestigious peer-reviewed journals, underlining our passion for advancing the healthcare sector. At HumanFirst, we are devoted to fostering safe, effective, and equitable healthcare practices within home settings, striving to ensure that every patient receives the highest quality of care available. By continuously evolving our technologies and methodologies, we endeavor to keep pace with the changing landscape of healthcare delivery.

Altis Labs has introduced Nota, a groundbreaking platform aimed at improving the efficiency of therapeutic research and development in the clinical field. By leveraging artificial intelligence, Nota assesses imaging data to forecast patient outcomes, enabling sponsors to better concentrate on their most viable therapies. This cutting-edge tool equips researchers with the ability to utilize imaging data from clinical trials, access predictive biomarkers, and accelerate research initiatives on a broader scale. With Altis' cloud-based software that employs deep learning techniques, biopharma companies can achieve comprehensive outcome predictions at the levels of individual images, patients, and entire cohorts, thereby enhancing the design of clinical trials and boosting confidence in predicting clinical endpoints. The insights provided by Nota hold the potential to significantly shorten development timelines, reduce drug development costs, and increase the likelihood of success in clinical trials across diverse therapeutic areas. Furthermore, Nota signifies a major leap forward in the fusion of technology with clinical research, ultimately paving the way for more streamlined and effective drug development methodologies. This innovation not only promises to transform the landscape of clinical trials but also aims to improve patient outcomes in the long run.

Our tailored tracking solution is specifically designed for clinical trials, allowing trial managers to effortlessly download the app onto their mobile devices. With TruLab's sophisticated blockchain technology managing all intricate details, you can have peace of mind throughout the process. You no longer have to wait for samples to reach a central lab to spot potential issues; instead, you can monitor data irregularities in real-time as samples navigate through the clinical trial stages. TruLab supports continuous remote accessioning of samples, effectively tackling the notable problem that 20% of samples are either lost or rendered unusable in late-stage trials, a situation that raises ethical, logistical, and financial concerns. As the trend of collecting samples at participants' homes grows, it introduces new challenges in tracking these specimens. TruLab proficiently oversees samples no matter their location, guaranteeing their accountability from participants' residences to storage facilities, thereby bolstering the integrity of the clinical trial process. Moreover, by delivering seamless tracking functionalities, TruLab not only empowers trial managers to reduce risks but also enhances the likelihood of achieving favorable outcomes. Ultimately, this innovative solution streamlines the entire clinical trial journey, ensuring that every sample is meticulously monitored every step of the way.

The complexity of Modern Interactive Response Technology (IRT) systems is on the rise. The importance of customizable and adaptable IRT solutions is paramount, as these systems are crucial for gathering vital information such as recruitment statistics, clinical trial dropout rates, and patient participation. Choosing a user-friendly, mobile-optimized, and comprehensive platform is essential, built on a foundation of quality, flexibility, and expertise. It is essential to engage with a partner that possesses deep therapeutic insights relevant to today’s risk-based eClinical environment. By integrating state-of-the-art technology with specialized expertise and a commitment to outstanding service, we significantly improve clinical trials, ultimately leading to better patient outcomes. Our profound knowledge of clinical workflows and supply chain intricacies drives innovation, empowering clients with enhanced control over their Randomization and Trial Supply Management (RTSM) processes. Our revolutionary tools not only boost quality assurance but also substantially increase site efficiency and patient adherence. Additionally, our versatile IRT platform is designed to accommodate a diverse range of studies and can achieve complete validation and deployment within just 30 days, thereby optimizing clinical trial procedures. This rapid rollout facilitates quicker data acquisition and contributes to a more streamlined overall trial management experience, ultimately paving the way for more effective clinical research outcomes.

Science 37 is an innovative clinical research organization that specializes in decentralized clinical trials using its unique Metasite model, which removes the necessity for physical locations, enabling patients to participate in studies from nearly any location. This approach significantly increases accessibility, allowing over 90% of individuals who may typically be excluded from traditional site-based research to take part, and it boasts recruitment capabilities similar to those of 20 sites concentrated in one area, providing patients with the flexibility they seek. The Metasite leverages a proprietary platform that simplifies study management and enhances workflow for both patients and research personnel, all while ensuring efficient data capture without the need for manual reentry. By consolidating staff, processes, and technology, this model ensures built-in compliance with protocols, leading to improved adherence rates and the collection of high-quality data. Furthermore, Science 37's committed in-house medical professionals, telemedicine investigators, and mobile nursing teams possess extensive experience in managing remote trials across a wide variety of therapeutic areas, guaranteeing extensive outreach and support. This dedication to pioneering trial methodologies establishes Science 37 as a leader in reshaping the clinical research landscape, thereby opening new avenues for patient engagement and participation.

VIPER enhances the screening process by automating the identification of remote patients at the diagnosis phase, thereby ensuring that qualified candidates are enrolled. Utilizing artificial intelligence, the system adeptly aligns patients with precision trials during a vital enrollment window, drawing on lab-agnostic genomic data, electronic medical records (EMR), and pathology data that cater to individual patient profiles and specific research demands. The specialized matching engine rigorously searches for the most appropriate clinical trials that correlate with a patient's diagnosis as soon as it is made. Moreover, VIPER integrates seamlessly into existing workflows, providing real-time notifications about patient eligibility for ongoing trials, which keeps the entire healthcare team informed during this critical period. In addition to these features, VIPER incorporates interactive dashboards that facilitate extensive data mining, enabling the collection and analysis of site and study-level patient information to effectively achieve study key performance indicators (KPIs). This holistic strategy not only boosts the efficiency of trial recruitment but also significantly aids researchers in reaching their objectives with greater success. By continuously refining its processes, VIPER stands to further revolutionize the landscape of clinical trial enrollment.

DoubleJump Interchange is a cloud-based collaborative platform that integrates data from clinical settings and real-world scenarios to foster collaboration between researchers and healthcare professionals, with the ultimate goal of improving consumer health outcomes. Consumers, alongside their comprehensive care teams, gain access to a wide range of health information gathered from hospitals, clinics, and remote monitoring technologies, which empowers them to participate in personalized and timely disease prevention and management supported by social networks. Researchers are equipped with an extensive array of clinical, molecular, and real-world data, which aids in the identification of novel disease targets and the discovery of biomarkers that accurately predict treatment responses. By promoting the exchange of clinical knowledge among a network of healthcare providers, the platform aims to uphold the ideals of precision medicine. Additionally, it enhances the speed at which complex data sets are made available, thus spurring innovation in both translational research and healthcare delivery systems. This integrated framework not only fosters stronger collaboration but also underpins the broader mission of improving health outcomes for consumers, while potentially paving the way for future advancements in the field. The synergy created by this platform may lead to new insights and breakthroughs in the healthcare landscape.

Clinion eCOA facilitates the execution of decentralized clinical trials, enabling patients to participate from the comfort of their own homes. With the use of their smartphones, study participants can conveniently report their health status, allowing healthcare professionals to monitor them in real time. The integration of Clinion eCOA with Clinion EDC ensures that trial participants can enter daily outcomes directly into the system, effectively reducing issues related to data duplication and transcription errors while granting clinicians a continuous overview of patient progress. Additionally, the eCOA app supports multilingual forms, enhancing patient engagement and resulting in cleaner data collection. This decentralized approach not only streamlines the recruitment process but also accelerates patient enrollment, broadening the reach of clinical trials significantly. Overall, Clinion eCOA represents a pivotal advancement in the efficiency and effectiveness of clinical research.

Folio3 Digital Health presents a comprehensive Clinical Trial Management Software (CTMS) designed as a web-based solution to significantly improve the overall effectiveness of the clinical trial lifecycle for pharmaceutical companies, contract research organizations (CROs), and research institutions. This innovative platform integrates multiple trial operations, streamlining processes from planning and site management to data collection and reporting while ensuring compliance with international standards such as FDA 21 CFR Part 11, GxP, and HIPAA regulations. With an emphasis on user-friendly interface designs and real-time dashboards, the software is adept at managing clinical trials of all sizes efficiently. Included in the system are specialized modules for initiating studies, which allow users to define protocols, establish timelines, and create budgets through customizable templates that meet their specific requirements. Additionally, the site management capabilities facilitate the tracking of investigator credentials, contracts, and financial transactions, alongside patient recruitment features that simplify the screening process, monitor enrollment, and organize visit schedules, complete with automated reminders to boost participant involvement. The platform's adaptable nature ensures its relevance for a variety of stakeholders in clinical research, ultimately fostering a more cohesive and effective trial management experience, which is essential for advancing medical knowledge and improving patient outcomes. Furthermore, its robust analytics tools provide valuable insights that can enhance decision-making throughout the trial process.

Leapcure is a leader in the realm of patient recruitment and engagement, effectively connecting clinical trial sponsors with qualified participants. Utilizing state-of-the-art technology and innovative strategies, we are dedicated to increasing both the enrollment rates in trials and the overall outcomes for patients. Our platform streamlines the recruitment process, enabling the quick and effective identification of candidates for clinical studies. With a firm commitment to advancing medical research, Leapcure seeks to enhance the inclusivity and significance of clinical trials. We work closely with sponsors and participants alike to facilitate seamless and productive trial experiences, which are essential for the development of new therapies and treatments. By improving access to clinical trials, we are not only creating a more efficient pathway for medical advancements but also empowering patients to play a crucial role in the evolution of healthcare solutions. Ultimately, our mission is to transform the landscape of clinical research for the better.

With over twenty years of experience in software development and clinical research, Arone provides an extensive suite of tools specifically tailored for the entry and management of patient data in clinical research organizations. Our ready-to-use solutions come with dedicated support to guarantee the successful implementation of your studies and projects. By utilizing a unified platform, we simplify the collection and management of patient information. Furthermore, Arone streamlines the randomization process, ensuring that treatment assignments for study participants are done fairly to reduce bias. This approach not only enables participants to efficiently manage their daily data submissions but also offers personalized support for their individual projects. Our dedication lies in improving the efficiency and accuracy of clinical research through our cutting-edge solutions, paving the way for more effective studies. With a focus on innovation, we are committed to transforming the landscape of clinical trials.

Accelerating the development of essential drugs while guaranteeing equitable access to high-quality cancer therapies and research for patients globally is paramount. Our innovative technology is revolutionizing patient access to state-of-the-art medications and participation in clinical trials. FICS represents a pioneering software solution that streamlines the collection of regulatory-compliant data during patient treatment. By unifying disparate and previously disconnected applications into a cohesive and efficient platform, FICS enhances the speed and quality of clinical trials, which significantly improves patient outcomes. This transformative approach not only simplifies the trial process but also fosters better collaboration among researchers and healthcare providers.

The TCS ADD platform greatly accelerates the process by which pharmaceutical companies launch new products, streamlining clinical research and development to create more agile and secure trials. By promoting digital ecosystems and simplifying complex data management tasks, TCS ADD ensures faster delivery of innovative and effective treatments to patients. This platform leverages the TCS Decision FabricTM, a sophisticated cognitive AI engine, combined with smart analytics and the Internet of Things, providing significant business benefits to the pharmaceutical industry. It is a thorough, metadata-driven solution that adheres to industry standards and meets sponsor requirements for clinical trials. Moreover, this platform harnesses artificial intelligence and machine learning to speed up decision-making, facilitate rapid study initiation, and apply targeted interventions effectively. By digitizing the entire management of clinical trial supply chains while focusing on patient safety, this solution enhances both overall effectiveness and the patient experience during trials. In summary, TCS ADD not only modernizes clinical trial management but also adapts to the changing demands of the healthcare landscape, ensuring a more efficient and patient-centric approach. Through its innovative strategies, TCS ADD is paving the way for the future of clinical research and development.

AssisTek emerges as a leader in advanced clinical technology solutions specifically designed for clinical research, offering specialized software that enhances the process of collecting patient data. With a rich history spanning over 25 years, the organization has successfully supported more than 800 clinical research trials across 46 therapeutic areas, including over 500 multinational Phase I–IV trials. Their electronic Clinical Outcome Assessment (eCOA) solutions are marked by scalability, customization, and efficiency, all powered by a dependable cloud-based technology platform. Among their diverse range of products are the TEK eCOA Tablet, adaptable for any questionnaire used in clinical trials, TEK eDiary, which allows for the collection of patient-reported outcomes from home, TEK Configurator for thorough project development in clinical trials, and TEK Study Portal, which integrates eClinical tracking, training, and reporting into a single, user-friendly platform. AssisTek's pioneering systems and services have made them the go-to partner for data collection and analytics, earning the confidence of both patients and healthcare professionals. As they innovate further, AssisTek continues to focus on improving the effectiveness and precision of clinical research methodologies while exploring new avenues to advance the field. Their commitment to excellence ensures they stay at the forefront of technological advancements in clinical research.

Lindus Health is revolutionizing clinical trials by offering a comprehensive solution that delivers faster and more trustworthy results. Our integrated approach merges full-service CRO capabilities, effective site management, and advanced technology to enhance every aspect of your research, from the initial design phase to the ultimate delivery of data. By leveraging our agile in-house technology, we streamline site setup and patient recruitment, utilizing a rich database of over 30 million electronic health records to expedite the enrollment process. Our transparent pricing structure, based on fixed milestones and pay-on-results, effectively aligns our goals with those of our clients, eliminating the possibility of unexpected costs and delays. With an outstanding average satisfaction rating of 9.7 out of 10, our skilled and committed clinical operations team strives for excellence at each step of the process. In a short span of time, Lindus Health has expanded its global presence, successfully managing over 91 trials in various therapeutic fields, including metabolic health, women's health, diagnostics, and medical devices, all while upholding a strong emphasis on innovation and quality in clinical research. This unwavering commitment to efficiency and reliability solidifies Lindus Health’s position as an industry leader, ensuring that we continue to push the boundaries of what is possible in clinical trials. By prioritizing both patient experience and research integrity, we aim to set new standards that will benefit the future of healthcare.

Data is sourced from multiple avenues such as EDC, EHR, smartphones, mobile devices, and central laboratories. Prism adeptly assimilates this varied data and converts it into actionable insights. By fusing user-friendliness with state-of-the-art features, Prism EDC offers a contemporary method for the collection and management of clinical trial data. In addition to conventional form-based data collection, Prism also aggregates and organizes information from a myriad of sources. Moreover, Prism eSource introduces a revolutionary software solution that allows research teams to directly extract clinical trial data from a site's electronic health record (EHR). This advancement not only boosts efficiency and cuts costs when compared to the previous model—where sites had to repetitively enter the same data into various systems—but also accelerates the process of making new therapies available to patients in need. Consequently, the healthcare sector stands to gain immensely from the efficient processes that Prism enables, ultimately improving patient outcomes and enhancing the quality of care.

Enhance patient care by moving beyond conventional in-person visits, utilizing video consultations, remote monitoring, and the digital therapeutic capabilities offered by Oracle Health’s all-encompassing virtual care solutions. By actively tracking vital health indicators, you can create a cooperative relationship between patients and healthcare providers through Oracle Health’s Remote Patient Monitoring features. Patients can easily engage with their clinicians' monitoring programs using their own devices, ensuring seamless access to care. The health information gathered during clinical interactions will provide timely alerts and notifications, improving overall responsiveness to patient needs. By offering care in the comfort of patients' homes through a blend of video appointments and Oracle Health Remote Patient Monitoring, complemented by digital therapeutic functions, you can significantly enhance patient satisfaction. Encouraging clinicians to adopt these innovative tools can also improve their work-life balance, allowing them to operate more efficiently within an integrated virtual care framework. This strategy promotes ongoing monitoring of critical health data directly within the electronic health record (EHR) system, facilitating comprehensive patient management. Ultimately, this method not only enriches the patient experience but also strengthens the entire healthcare delivery framework, making care more accessible and effective for everyone involved. By ensuring that patients receive consistent support, the healthcare system can adapt to their evolving needs more responsively.

Improve the robustness of your evidence by utilizing advanced electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Reported Outcomes (eClinRO). These electronic assessments, collectively referred to as eCOA, effectively capture patients' emotions and functional capabilities during clinical trials. By adopting an electronic approach to clinical data collection, you ensure that the information gathered from patients is not only of superior quality but also adheres to necessary regulatory guidelines. Essentially, eCOA addresses the pitfalls associated with traditional paper diaries, such as readability issues, transcription errors, and data inconsistencies. Moreover, the FDA encourages the implementation of ePRO, which allows patients to express their health experiences through various questionnaires, potentially covering aspects like quality of life and daily activity levels. Conversely, clinician-reported outcomes involve assessments conducted by healthcare professionals, including evaluations such as physical examinations like the Psoriasis Area and Severity Index (PASI). Additionally, performance outcomes assess a patient's capability to perform specific tasks, including timed activities, thereby providing a holistic perspective on their health. In conclusion, embracing eCOA and its related strategies represents a significant advancement toward enhancing the reliability and efficiency of clinical trial methodologies, ultimately benefiting patient care. This shift not only streamlines data collection but also fosters greater patient engagement in their health management.

Advanced Health Intelligence (AHI) focuses on delivering health risk assessments that utilize digital biomarkers, enabling proactive health risk management for varied populations globally with user-friendly, smartphone-compatible solutions. Our comprehensive digital health assessments provide detailed insights into cardiovascular, metabolic, and mental health risks, ensuring that users fully appreciate their health status. The innovative FaceScan feature quickly estimates essential health metrics through the web or a smartphone using camera-sensor technology, with results generated in around two minutes. In addition, BodyScan allows users to analyze their body composition and dimensions, along with associated health risks, all from the comfort and privacy of their homes. AHI's cutting-edge solutions support population risk stratification, improve access to preventive healthcare, and deliver contactless, non-invasive risk assessments through easy self-administration that encourages engagement with remote communities. Our unique range of healthcare technologies is further distinguished by patents in multiple countries, highlighting our dedication to advancing health intelligence on a global scale. By leveraging state-of-the-art technology, AHI aspires to transform how individuals evaluate and manage their health risks, fostering a more informed and health-conscious society. Ultimately, this innovative approach empowers users to take charge of their health journeys with confidence and ease.

Sano Genetics offers an all-encompassing platform tailored for precision medicine and clinical trial initiatives, seamlessly merging elements such as patient recruitment, genetic analysis, informed consent, and continuous participant interaction to significantly optimize research workflows. This platform enables the development of customized protocols and the assembly of ethical submission materials, while also implementing digital prescreening and consent processes, as well as recruitment support through targeted online marketing, collaborations, and advocacy initiatives, thereby facilitating connections between sponsors, contract research organizations, and specific patient demographics that are frequently underserved in various areas. In addition, Sano provides accessible, non-invasive saliva-based DNA testing kits that present a cost-effective alternative to conventional blood draws, alongside logistical support for the collection and processing of samples. Their offerings extend to reliable genetic and biomarker evaluations from accredited labs, bioinformatics solutions, and the communication of results, enhanced by genetic counseling when appropriate, which collectively ensure a comprehensive approach to patient management and study integrity. Furthermore, by harnessing advanced technology and fostering community involvement, Sano Genetics is set to revolutionize the field of clinical trials and personalized healthcare, paving the way for more inclusive and efficient medical research. This innovative approach not only benefits sponsors but also prioritizes the needs of diverse patient populations.